Doctor profile · Federal record
Dr. Temitayo Ogunleye, MD
Dermatology Physician (CMS: Dermatology) · Dermatology Physician · Philadelphia, PA
- NPI 1891956595
- Accepts Medicare
- MIPS 85.5 / 100 · 2023
- 18 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3400 Spruce Street, 2 Rhoads Pavilion
Philadelphia, PA 19104
(215) 662-2737
fax (215) 349-8339
Credentials & registration
- NPI registered
- June 2008 — 18 yrs on file
- Profile last updated
- July 2, 2013
- Year of graduation
- 2008 — 18 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State licenses (2)
- Pennsylvania #MD446369 · New Jersey #25MA09329100
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1891956595. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,646
Distinct HCPCS
10
Medicare allowed
$97,445
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 657 | 110 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 232 | 183 | $96 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 204 | 148 | $137 | |
17000 |
Destruction of precancer skin growth, 1 growth | 170 | 133 | $62 | |
17110 |
Destruction of skin growth, 1-14 growths | 88 | 80 | $125 | |
11102 |
Biopsy of related skin growth, first growth | 71 | 60 | $106 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 53 | 36 | $101 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 50 | 11 | $2 | |
11103 |
Biopsy of related skin growth, each additional growth | 35 | 19 | $56 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 31 | 26 | $69 |
In context: peer comparison
Among 55 peers in this city , average services per provider: 169. This provider delivers 9.7× the peer median.Medicare Part D · 2023
Top prescriptions
Total claims
760
Patients
279
Total drug cost
$170,836
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 145 | 60 | $4,098 |
| Clobetasol Propionate | Generic | 119 | 60 | $8,348 |
| Triamcinolone Acetonide | Generic | 100 | 76 | $1,087 |
| Minoxidil | Generic | 82 | 22 | $838 |
| Dupixent Pen (Dupilumab) | Brand | 40 | 0 | $145,202 |
| Finasteride | Generic | 34 | 0 | $294 |
| Doxycycline Hyclate | Generic | 33 | 0 | $824 |
| Dutasteride | Generic | 33 | 0 | $779 |
| Mycophenolate Mofetil | Generic | 31 | 0 | $2,613 |
| Clindamycin Phosphate | Generic | 27 | 15 | $931 |
Hospital affiliations
Frequently asked questions
What is Dr. Temitayo Ogunleye's medical specialty?
Dr. Temitayo Ogunleye practices Dermatology Physician in Philadelphia, PA.
Where does Dr. Temitayo Ogunleye practice?
Dr. Temitayo Ogunleye practices at 3400 Spruce Street, Philadelphia, PA 19104. Office phone: 2156622737.
What is Dr. Temitayo Ogunleye's NPI?
Dr. Temitayo Ogunleye's National Provider Identifier (NPI) is 1891956595, issued by NPPES.
Does Dr. Temitayo Ogunleye accept Medicare assignment?
Yes. Dr. Temitayo Ogunleye accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Temitayo Ogunleye commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.